logo
I recovered from booze & drug addiction then piled on 3 stone – Mounjaro was the only thing that helped

I recovered from booze & drug addiction then piled on 3 stone – Mounjaro was the only thing that helped

The Sun03-06-2025
CAT Sims has opened up about turning to Mounjaro after quitting booze and drugs lead her turning to food and piling on three stones.
Author and podcaster Cat, 43, from London, hailed the weight loss jab as 'rehab for food' and praised it for being a 'silver bullet.'
8
8
Cat has previously opened up about battling an alcoholic and drug addiction - but managed to kick the habit of having a bottle of wine a night and taking cocaine regularly.
However, she then struggled with food.
Speaking on the podcast, Made by Mammas, she candidly shared that she is 'all or nothing' and food is a 'big issue for her.'
Cat, who is married to husband Jimmy and has two daughters, Billie and Bo, explained: 'I think actually that was probably my first addiction.
'But for me, I'm sure there are people who can balance who can moderate. I do not have that gene.
'I've recently started Mounjaro, I've recently started the weight loss jabs.
'I was three stone heavier than I was when I gave up booze.
'I think people think if you give up booze you're going to lose a little weight.
'I lost nothing. I just went straight into food and chocolate and sugar.'
She then explained how Mounjaro has helped her 'food addiction', and said: 'For me it's like rehab for food addiction.
'You're locked down and while you're there you do all the work, so that when you come out of rehab you can do it on your own.
'And that's what Mounjaro is for me.'
Cat shared how she feels like her food addiction is now gone thanks to the controversial weight loss jab.
8
8
8
She added: 'I have no cravings for the crappy food or the ultra processed stuff.
'It was always a difficult thing because with booze and alcohol I was always like I can just abstain, I don't have to have those things, but food, I can't just not eat.
'But now I think doing the work I'm doing while I'm on the injections has made me realise that I can abstain from the ultra processed stuff.
'There are side effects, as there are with any drug or medication or anything that you put into you that isn't naturally supposed to be, but for me, it's been a silver bullet in terms of helping me manage what is essentially a food addiction, you know, and also I'm perimenopausal.'
8
8
8
MOUNJARO TAKEOVER
Mounjaro injections are licensed for patients with type 2 diabetes and are administered every seven days.
They are also available to assist those who are clinically obese (with a Body Mass Index of 30 or over).
The drugs, which have been widely regarded as 'fat jabs', can be prescribed by a practitioner - such as a doctor, nurse or a pharmacist-independent prescriber.
But increasingly, we are seeing more and more people buying them through online pharmacies, without sufficient checks.
Not only this, but recently, figures from the Medicines and Healthcare products Regulatory Agency revealed that fat jabs had been linked to 82 deaths across the UK.
Everything you need to know about fat jabs
Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases.
Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK.
Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market.
Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year.
How do they work?
The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight.
They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists.
They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high.
Can I get them?
NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics.
Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure.
GPs generally do not prescribe the drugs for weight loss.
Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk.
Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health.
Are there any risks?
Yes – side effects are common but most are relatively mild.
Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea.
Dr Sarah Jarvis, GP and clinical consultant at patient.info, said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.'
Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia.
Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health.
Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What to know about bovine tuberculosis as disease hits Diddly Squat Farm
What to know about bovine tuberculosis as disease hits Diddly Squat Farm

The Independent

time24 minutes ago

  • The Independent

What to know about bovine tuberculosis as disease hits Diddly Squat Farm

Jeremy Clarkson 's Diddly Squat Farm in the Cotswolds has been hit by an outbreak of bovine tuberculosis (bTB) among its cattle. Clarkson announced on 31 July that the farm team was "devastated" after a pregnant cow contracted the disease, with tests for the beloved bull Endgame proving inconclusive. Following failed biannual tests for some cattle, the farm is now under restrictions, preventing the buying or selling of cows, though the Diddly Squat shop remains unaffected. The infected pregnant cow, carrying twins, will be culled, a decision Clarkson described as "awful" and emotionally distressing for the farm. Bovine TB is a chronic respiratory disease that primarily affects cattle, often leading to culling to control its spread, though human transmission is very rare. What is bovine tuberculosis? Everything you need to know about the disease affecting Jeremy Clarkson's Diddly Squat farm

Alzheimer's ‘wonder drug' slows progression of disease by four years - and could even reverse it
Alzheimer's ‘wonder drug' slows progression of disease by four years - and could even reverse it

The Independent

time24 minutes ago

  • The Independent

Alzheimer's ‘wonder drug' slows progression of disease by four years - and could even reverse it

An Alzheimer's 'wonder drug' can delay the progression of the disease by four years, according to a new study. Researchers found that patients who were given the drug lecanemab in the earliest days of their disease reported an improvement, or no decline at all, in cognitive function. The trial of 478 patients who stayed on the drug for four years saw their dementia score rise by an average of 1.75 over the whole period - a score significantly lower than the average rise of one or two points over one year. Almost one million people in the UK suffer from dementia, with Alzheimer's the most common form of the disease. Urgent demand for new treatments is increasing as the number is expected to rise to 1.4 million by 2040. The new data presented at the Alzheimer's Association International Conference in Toronto suggested the drug was most promising for those with low levels of tau, the protein that grows as Alzheimer's progresses. In a subgroup of patients with low levels of tau, promising results showed 69 per cent of the group had no decline at all over four years, and 56 per cent saw an improvement in their cognitive scores. Speaking to The Telegraph, Professor Christopher Van Dyck, the director of the Alzheimer's Research unit at the Yale school of medicine and the study leader, said: 'The thing I really focus on is the time saved. You will get worse over time, but it will take longer to get there.' Lecanemab was approved for use in the UK last year after trials showed its effectiveness in slowing the progression of the disease. It is a disease-modifying drug, which means that it was developed to tackle the causes of Alzheimer's disease rather than only relieving the symptoms. It works by targeting the protein amyloid, which is thought to build up in the brain and become toxic to brain cells, causing Alzheimer's symptoms. Other similar drugs, like donanemab, have also been shown to slow the rate at which memory and thinking get worse by more than 20 per cent. Both drugs are approved by the Medicines and Healthcare products Regulatory Agency (MHRA) but were rejected for use by the NHS because the benefits were deemed to be 'too small' to justify the cost. Dr Sheona Scales, the director of research at Alzheimer's Research UK, told The Telegraph: 'These latest findings offer renewed hope that Alzheimer's treatments can meaningfully change the course of the disease, not just slow decline in the short term. 'New long-term data show that the benefits of donanemab may continue even after treatment ends, and people on lecanemab for up to four years maintained cognitive gains, with some even improving. Among those treated early with lecanemab and with low levels of tau, over half showed no decline after four years. 'This is the first wave of disease-modifying treatments for Alzheimer's and, while the progress is encouraging, there are still many pieces of the puzzle we don't yet have.'

Jersey fundraiser finishes challenge in memory of her mum
Jersey fundraiser finishes challenge in memory of her mum

BBC News

time24 minutes ago

  • BBC News

Jersey fundraiser finishes challenge in memory of her mum

A Jersey fundraiser finished her challenge to run 5k (3.2miles) every day through the month of July in memory of her Daly's mum, Nicola, died from malignant melanoma five years ago, which is a type of skin cancer that can spread to other areas of the 27-year-old has raised more than £6,400 for MacMillan Jersey, which supported her mum during her cancer Daly was joined by friends and family throughout her runs and they gathered at the Waterfront Gardens to cheer her on as she finished the challenge. Ms Daly has been sharing her challenge on social media to also make more people aware of the dangers of skin said: "People think it's just skin cancer and you can cut it out and it's gone but that wasn't the case with my mum and it's not the case for a lot of people."Ms Daly added: "The most emotional thing was I just wish she was here," adding: "She would've been there every step of the way and I know she is there but I can't see her or talk to her".It was an emotional finish to the fundraising as Ms Daly shed some tears as she crossed the finish line, and also said: "I've never done anything like this before". Megan Winton was one of the runners who joined Ms Daly on her final run on said it was "for a great cause" and "whatever we could do to help, we jumped up to it"."It was emotional and I'm glad I had my sunglasses as we all got a little bit choked up because it was so beautiful and it's what it's all been about," Ms Winton. Andrew Gardham from MacMillan Jersey liaised with Ms Daly on her fundraising challenge for the cancer said: it was "absolutely fantastic to see Daisy finish off after all of her hard work", and that it was "really important for us to have fundraisers like Daisy".Mr Gardham added: "Not only has Daisy raised fantastic funds but also by sharing her story so bravely, it's been so impactful for other people to be diligent and to be careful in the sun." MacMillan Jersey advises that people stay in shade when the sun is at its strongest, cover up skin when UV rays are high and wear suncream on exposed skin to reduce the risks of getting skin cancer.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store